Janus sees big potential for Asian healthcare stocks
China and India spend just 3% of GDP on healthcare, as against 16% in the US, but that figure is set to grow far faster than in developed markets, says Andy Acker of Janus Capital.
Andy Acker is portfolio manager and equity research analyst for healthcare at Janus Capital in Denver, Colorado.
Since April 2007, he has managed the Janus Global Life Sciences strategy and Janus Global Life Sciences Fund. Acker served as co-portfolio manager of the Janus Aspen Global Life Sciences portfolios from October 2004. He also serves as team leader of the healthcare sector research team.
Acker joined Janus in August 1999 as an equity research analyst, focusing on companies …
Please sign in or register
for free access to 1 article per month from AsianInvestor’s content and archives of over 16,000 articles.